These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29233297)

  • 21. Mimicking Strategy for Protein-Protein Interaction Inhibitor Discovery by Virtual Screening.
    Wu KJ; Lei PM; Liu H; Wu C; Leung CH; Ma DL
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studying protein-protein interactions: progress, pitfalls and solutions.
    Hayes S; Malacrida B; Kiely M; Kiely PA
    Biochem Soc Trans; 2016 Aug; 44(4):994-1004. PubMed ID: 27528744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery.
    Long MJC; Hnedzko D; Kim BK; Aye Y
    Chembiochem; 2019 May; 20(9):1091-1104. PubMed ID: 30589188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative modulation of protein-protein interactions by small molecules.
    Fischer G; Rossmann M; Hyvönen M
    Curr Opin Biotechnol; 2015 Dec; 35():78-85. PubMed ID: 25935873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecules modulation of 14-3-3 protein-protein interactions.
    Mori M; Vignaroli G; Botta M
    Drug Discov Today Technol; 2013 Dec; 10(4):e541-7. PubMed ID: 24451646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of protein-protein interactions using designed molecules.
    Wilson AJ
    Chem Soc Rev; 2009 Dec; 38(12):3289-300. PubMed ID: 20449049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemical libraries dedicated to protein-protein interactions].
    Sperandio O; Villoutreix BO; Morelli X; Roche P
    Med Sci (Paris); 2015 Mar; 31(3):312-9. PubMed ID: 25855285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
    Demirel HC; Dogan T; Tuncbag N
    Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generating Potential Protein-Protein Interaction Inhibitor Molecules Based on Physicochemical Properties.
    Ohue M; Kojima Y; Kosugi T
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between intrinsically disordered proteins frequently occurs in a human protein-protein interaction network.
    Shimizu K; Toh H
    J Mol Biol; 2009 Oct; 392(5):1253-65. PubMed ID: 19660471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Cascade Random Forests Algorithm for Predicting Protein-Protein Interaction Sites.
    Wei ZS; Yang JY; Shen HB; Yu DJ
    IEEE Trans Nanobioscience; 2015 Oct; 14(7):746-60. PubMed ID: 26441427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.
    Sheng C; Dong G; Miao Z; Zhang W; Wang W
    Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
    Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
    BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.
    Chen TC; Lin KT; Chen CH; Lee SA; Lee PY; Liu YW; Kuo YL; Wang FS; Lai JM; Huang CY
    J Proteome Res; 2014 Dec; 13(12):5339-46. PubMed ID: 25241761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
    Scott DE; Bayly AR; Abell C; Skidmore J
    Nat Rev Drug Discov; 2016 Aug; 15(8):533-50. PubMed ID: 27050677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular glues to stabilise protein-protein interactions.
    Soini L; Leysen S; Davis J; Ottmann C
    Curr Opin Chem Biol; 2022 Aug; 69():102169. PubMed ID: 35749929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.